Michael Doherty is a Bionanoparticle Development Leader with over 10 years of experience in early-phase downstream process development and GMP manufacturing. They have held various positions at companies such as Codiak BioSciences and Ring Therapeutics, advancing from Research Associate roles to Senior Scientist and Director. Currently, Michael leads purification development at Ring Therapeutics, drawing from a strong educational foundation that includes a B.A. in Biology from Saint Anselm College and an M.S. in Cell and Molecular Biology from Northeastern University. Their professional focus includes high-throughput process development and innovative technology for novel modalities.
This person is not in the org chart
This person is not in any teams
This person is not in any offices